Respiratory syncytial virus, or RSV, is a common respiratory virus that infects the nose, throat, and lungs and acts a lot like a common cold or mild flu, according to the CDC. It tends to spread ...

The CDC also mentioned respiratory syncytial virus (RSV), which is a virus that causes cold-like symptoms but also impacts breathing passages and the lungs. RSV has been trending upwards since ...

And, of course, wearing a mask won't hurt. Respiratory viruses that cause the common cold, respiratory syncytial virus (RSV), COVID-19 and flu peak at this time of year. Vaccines can help head off ...

Alone and in combination with other lower respiratory tract disease signs and symptoms, dyspnea is the best predictor of severe RSV outcomes.

Photo: Christoph Soeder/dpa (Photo by Christoph Soeder/picture alliance via Getty Images) Respiratory syncytial virus activity continues to rise in the United States, according to the latest ...

The following is a summary of “Respiratory syncytial virus vaccine effectiveness among US veterans, September, 2023 to March, 2024: a target trial emulation study,” published in the January 2025 issue ...

and RSV vaccines are available for certain groups of adults. Vaccination coverage remains low, however, meaning "many children and adults lack protection from respiratory virus infections provided ...